OTSUKA PHARMACEUTICAL CO., LTD.
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Public, Subsidiary
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.otsuka.co.jp
Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
Active, not recruiting
- Conditions
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 535
- Registration Number
- NCT04812379
- Locations
- π―π΅
Pharmacovigilance Department, Osaka, Japan
Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH
Recruiting
- Conditions
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT04790175
- Locations
- π―π΅
Pharmacovigilance Department, Osaka, Japan
A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-05-10
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 188
- Registration Number
- NCT04784442
- Locations
- π―π΅
Tokyo-Eki Center-Building Clinic, Chuo-ku,Tokyo, Japan
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 49
- Registration Number
- NCT04649073
- Locations
- π―π΅
Tokai University Hospital, Isehara-shi, Japan
π―π΅National Hospital Organization Okayama Medical Center, Okayama-shi, Japan
π―π΅Tohoku University Hospital, Sendai-shi, Japan
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04608110
- Locations
- π―π΅
Yamagata University Hospital, Yamagata, Japan
A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT04362007
- Locations
- π―π΅
Yamagata University Hospital, Yamagata, Japan
A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 71
- Registration Number
- NCT04355117
- Locations
- π―π΅
Sendai Zutsu No-Shinkei Clinic, Sendai, Japan
A Phase 2 Trial of OPC-64005 for Major Depressive Disorder
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 273
- Registration Number
- NCT04244253
- Locations
- π―π΅
Medical Corporation Jisenkai Himorogi Psychiatric Institute, Tokyo, Japan
A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT04182958
- Locations
- π¬π§
Covance Clinical Research Unit Ltd, Leeds, United Kingdom
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 73
- Registration Number
- NCT04118127
- Locations
- π―π΅
Sankeikai Nishigahara Hospital, Tokyo, Japan
Β© Copyright 2024. All Rights Reserved by MedPath